Zdrowie i gospodarka · 22/05/2013

FDA to Hold Public Meeting on Standardizing Risk Evaluation and Mitigation Strategies for Drug and Biological Products

The FDA is hosting a 2-day public meeting to gather input on standardizing and evaluating risk evaluation and mitigation strategies (REMS) for pharmaceuticals, as part of the reauthorization of the Prescription Drug User Fee Act (PDUFA) and the agency's commitment to improving the healthcare system.